Skip to main content
. 2014 Aug 12;83(7):628–637. doi: 10.1212/WNL.0000000000000686

Figure 2. Efficacy results.

Figure 2

(A) Estimated linear dose response for the intent-to-treat population using the MCP-Mod procedure with 80% point-wise confidence interval (CI). (B) Mean change from baseline in average pain intensity score to 4, 8, and 12 weeks in the double-blind efficacy phase (intent-to-treat population). Locf = last observation carried forward.